Limited window for donation of convalescent plasma with high live-virus neutralizing antibody titers for COVID-19 immunotherapy
Gontu et al. conducted a longitudinal study in COVID patients in which they assessed the response trajectories of antibodies directed to the SARS-CoV-2 surface spike glycoprotein and in vitro SARS-CoV-2 live virus neutralizing titers. Their measurements demonstrate the presence of an optimum window...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Nature Portfolio
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/29e9d16320ed452bba1c23cd05a61b50 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:29e9d16320ed452bba1c23cd05a61b50 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:29e9d16320ed452bba1c23cd05a61b502021-12-02T13:34:56ZLimited window for donation of convalescent plasma with high live-virus neutralizing antibody titers for COVID-19 immunotherapy10.1038/s42003-021-01813-y2399-3642https://doaj.org/article/29e9d16320ed452bba1c23cd05a61b502021-02-01T00:00:00Zhttps://doi.org/10.1038/s42003-021-01813-yhttps://doaj.org/toc/2399-3642Gontu et al. conducted a longitudinal study in COVID patients in which they assessed the response trajectories of antibodies directed to the SARS-CoV-2 surface spike glycoprotein and in vitro SARS-CoV-2 live virus neutralizing titers. Their measurements demonstrate the presence of an optimum window for convalescent plasma donation as well as predictions of the most suitable donor type.Abhinay GontuSreenidhi SrinivasanEric SalazarMeera Surendran NairRuth H. NisslyDenver GreenawaltIan M. BirdCatherine M. HerzogMatthew J. FerrariIndira PoojaryRobab KataniScott E. LindnerAllen M. MinnsRandall RossiPaul A. ChristensenBrian CastilloJian ChenTodd N. EagarXin YiPicheng ZhaoChristopher LevequeRandall J. OlsenDavid W. BernardJimmy GolliharSuresh V. KuchipudiJames M. MusserVivek KapurNature PortfolioarticleBiology (General)QH301-705.5ENCommunications Biology, Vol 4, Iss 1, Pp 1-9 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Biology (General) QH301-705.5 |
| spellingShingle |
Biology (General) QH301-705.5 Abhinay Gontu Sreenidhi Srinivasan Eric Salazar Meera Surendran Nair Ruth H. Nissly Denver Greenawalt Ian M. Bird Catherine M. Herzog Matthew J. Ferrari Indira Poojary Robab Katani Scott E. Lindner Allen M. Minns Randall Rossi Paul A. Christensen Brian Castillo Jian Chen Todd N. Eagar Xin Yi Picheng Zhao Christopher Leveque Randall J. Olsen David W. Bernard Jimmy Gollihar Suresh V. Kuchipudi James M. Musser Vivek Kapur Limited window for donation of convalescent plasma with high live-virus neutralizing antibody titers for COVID-19 immunotherapy |
| description |
Gontu et al. conducted a longitudinal study in COVID patients in which they assessed the response trajectories of antibodies directed to the SARS-CoV-2 surface spike glycoprotein and in vitro SARS-CoV-2 live virus neutralizing titers. Their measurements demonstrate the presence of an optimum window for convalescent plasma donation as well as predictions of the most suitable donor type. |
| format |
article |
| author |
Abhinay Gontu Sreenidhi Srinivasan Eric Salazar Meera Surendran Nair Ruth H. Nissly Denver Greenawalt Ian M. Bird Catherine M. Herzog Matthew J. Ferrari Indira Poojary Robab Katani Scott E. Lindner Allen M. Minns Randall Rossi Paul A. Christensen Brian Castillo Jian Chen Todd N. Eagar Xin Yi Picheng Zhao Christopher Leveque Randall J. Olsen David W. Bernard Jimmy Gollihar Suresh V. Kuchipudi James M. Musser Vivek Kapur |
| author_facet |
Abhinay Gontu Sreenidhi Srinivasan Eric Salazar Meera Surendran Nair Ruth H. Nissly Denver Greenawalt Ian M. Bird Catherine M. Herzog Matthew J. Ferrari Indira Poojary Robab Katani Scott E. Lindner Allen M. Minns Randall Rossi Paul A. Christensen Brian Castillo Jian Chen Todd N. Eagar Xin Yi Picheng Zhao Christopher Leveque Randall J. Olsen David W. Bernard Jimmy Gollihar Suresh V. Kuchipudi James M. Musser Vivek Kapur |
| author_sort |
Abhinay Gontu |
| title |
Limited window for donation of convalescent plasma with high live-virus neutralizing antibody titers for COVID-19 immunotherapy |
| title_short |
Limited window for donation of convalescent plasma with high live-virus neutralizing antibody titers for COVID-19 immunotherapy |
| title_full |
Limited window for donation of convalescent plasma with high live-virus neutralizing antibody titers for COVID-19 immunotherapy |
| title_fullStr |
Limited window for donation of convalescent plasma with high live-virus neutralizing antibody titers for COVID-19 immunotherapy |
| title_full_unstemmed |
Limited window for donation of convalescent plasma with high live-virus neutralizing antibody titers for COVID-19 immunotherapy |
| title_sort |
limited window for donation of convalescent plasma with high live-virus neutralizing antibody titers for covid-19 immunotherapy |
| publisher |
Nature Portfolio |
| publishDate |
2021 |
| url |
https://doaj.org/article/29e9d16320ed452bba1c23cd05a61b50 |
| work_keys_str_mv |
AT abhinaygontu limitedwindowfordonationofconvalescentplasmawithhighlivevirusneutralizingantibodytitersforcovid19immunotherapy AT sreenidhisrinivasan limitedwindowfordonationofconvalescentplasmawithhighlivevirusneutralizingantibodytitersforcovid19immunotherapy AT ericsalazar limitedwindowfordonationofconvalescentplasmawithhighlivevirusneutralizingantibodytitersforcovid19immunotherapy AT meerasurendrannair limitedwindowfordonationofconvalescentplasmawithhighlivevirusneutralizingantibodytitersforcovid19immunotherapy AT ruthhnissly limitedwindowfordonationofconvalescentplasmawithhighlivevirusneutralizingantibodytitersforcovid19immunotherapy AT denvergreenawalt limitedwindowfordonationofconvalescentplasmawithhighlivevirusneutralizingantibodytitersforcovid19immunotherapy AT ianmbird limitedwindowfordonationofconvalescentplasmawithhighlivevirusneutralizingantibodytitersforcovid19immunotherapy AT catherinemherzog limitedwindowfordonationofconvalescentplasmawithhighlivevirusneutralizingantibodytitersforcovid19immunotherapy AT matthewjferrari limitedwindowfordonationofconvalescentplasmawithhighlivevirusneutralizingantibodytitersforcovid19immunotherapy AT indirapoojary limitedwindowfordonationofconvalescentplasmawithhighlivevirusneutralizingantibodytitersforcovid19immunotherapy AT robabkatani limitedwindowfordonationofconvalescentplasmawithhighlivevirusneutralizingantibodytitersforcovid19immunotherapy AT scottelindner limitedwindowfordonationofconvalescentplasmawithhighlivevirusneutralizingantibodytitersforcovid19immunotherapy AT allenmminns limitedwindowfordonationofconvalescentplasmawithhighlivevirusneutralizingantibodytitersforcovid19immunotherapy AT randallrossi limitedwindowfordonationofconvalescentplasmawithhighlivevirusneutralizingantibodytitersforcovid19immunotherapy AT paulachristensen limitedwindowfordonationofconvalescentplasmawithhighlivevirusneutralizingantibodytitersforcovid19immunotherapy AT briancastillo limitedwindowfordonationofconvalescentplasmawithhighlivevirusneutralizingantibodytitersforcovid19immunotherapy AT jianchen limitedwindowfordonationofconvalescentplasmawithhighlivevirusneutralizingantibodytitersforcovid19immunotherapy AT toddneagar limitedwindowfordonationofconvalescentplasmawithhighlivevirusneutralizingantibodytitersforcovid19immunotherapy AT xinyi limitedwindowfordonationofconvalescentplasmawithhighlivevirusneutralizingantibodytitersforcovid19immunotherapy AT pichengzhao limitedwindowfordonationofconvalescentplasmawithhighlivevirusneutralizingantibodytitersforcovid19immunotherapy AT christopherleveque limitedwindowfordonationofconvalescentplasmawithhighlivevirusneutralizingantibodytitersforcovid19immunotherapy AT randalljolsen limitedwindowfordonationofconvalescentplasmawithhighlivevirusneutralizingantibodytitersforcovid19immunotherapy AT davidwbernard limitedwindowfordonationofconvalescentplasmawithhighlivevirusneutralizingantibodytitersforcovid19immunotherapy AT jimmygollihar limitedwindowfordonationofconvalescentplasmawithhighlivevirusneutralizingantibodytitersforcovid19immunotherapy AT sureshvkuchipudi limitedwindowfordonationofconvalescentplasmawithhighlivevirusneutralizingantibodytitersforcovid19immunotherapy AT jamesmmusser limitedwindowfordonationofconvalescentplasmawithhighlivevirusneutralizingantibodytitersforcovid19immunotherapy AT vivekkapur limitedwindowfordonationofconvalescentplasmawithhighlivevirusneutralizingantibodytitersforcovid19immunotherapy |
| _version_ |
1718392723957874688 |